SQS yields 8.20% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, SQS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SQS + PFE for your $10,000?
SQS is an actively managed ETF aiming for long-term total return by investing in companies expected to benefit from long-term themes and areas of change or growth. The fund selects companies with quality and growth characteristics across sectors. It starts by identifying catalysts believed to drive sustained growth over time, including broad trends or transformations reshaping the economy, labor markets, capital flows, or productivity (e.g., technological innovation, demographic shifts, policy changes, or evolving market conditions). It excludes sectors expected to be negatively affected and chooses companies likely to benefit from these themes. Screening involves quantitative and fundamental analysis, using a bottom-up approach to evaluate financial health, business fundamentals, and management. The fund may also invest in ETFs. As an actively managed ETF, the manager has full discretion to adjust holdings at any time, including quality and growth requirements.
Full SQS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.